A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp) in comparison to insulin aspart (NovoRapid) around exercise in participants with type 1 diabetes
Latest Information Update: 11 Aug 2022
At a glance
- Drugs Insulin aspart (Primary) ; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms NN-Ex-Fiasp
- 13 Jul 2020 Planned initiation date changed from 1 Mar 2020 to 1 Aug 2020.
- 24 Feb 2020 Planned initiation date changed from 24 Jun 2019 to 1 Mar 2020.
- 21 Jun 2019 New trial record